Roche Hungary's Economic Footprint in 2019

We have been working for 35 years to get Roche's most innovative medicines to the Hungarian patients. Since then, we have contributed to the treatment of the patients with 74 therapies.
Our mission is to close the gap between the Hungarian and European patients’ outcomes by building partnerships with Hungarian patients and the healthcare system’s stakeholders, utilizing Roche’s portfolio and beyond.

We're all unique. We differ from our fellow human beings in many ways, including our illnesses. Today, however, we treat diseases, symptoms, or reasons rather than individual patient cases. While we know human biology and our diseases better than ever before, the usual routine and patterns of healthcare are still predominant as of 2020. Personalised healthcare (medicine) is aimed at leaving behind this approach.

We strive to continuously create value for our partners supporting the sustainability of the Hungarian healthcare. We do it with our commitment to R&D activities, ensuring our continuous development, and creating new jobs. We returned almost ¾ of our revenue back into the Hungarian economy helping its development.

Roche offers medicinal products for treatments primarily in oncology, immunology, haematology, diseases of the central nervous system and certain rare diseases.
In recent years, there has been a steady increase in the number of therapeutic areas where Roche medicines are utilised. Some Roche formulations are used in every hospital in Hungary, especially in the treatment of oncology patients.

Clinical trials have now become an indispensable part of patient care in Hungary. With their help, otherwise extremely costly therapies are becoming available to patients free of charge under highly controlled conditions, closely monitoring the efficacy and safety of investigational medicinal products.
In 2019, Roche conducted 64 clinical trials in 6 therapeutic areas in Hungary.

In addition to the three business units of Roche present in Hungary – pharma, diagnostics, and diabetes care – we also have a shared services and solution center and a new pharmacovigilance hub in Hungary. The PV HUB Budapest is responsible for 23 European countries and 6 countries from Balkan Peninsula and started its operation last September. This global unit creates new highly-skilled workforces and plays a critical role in ensuring drug safety across Europe. The team plays a crucial role in capturing and analyzing data from real world usage and clinical trials.

The most important task of Roche’s diagnostics business is to develop, optimise, maintain and service in vitro laboratory processes in the healthcare system, scientific research and education.
In our partner laboratories 43,000 tests are carried out daily using Roche solutions. This equates to16 million tests annually.
Some 70% of the pathology laboratories supporting oncology care in the country use Roche histological diagnostics solution.

The vision of Roche Diabetes Care is to help people with diabetes everywhere in the world think less about their daily diabetes routine so they can get true relief, day and night. For over 40 years and with its Accu-Chek brand, Roche Diabetes Care has been dedicated to enabling people with diabetes to live life as normal and active as possible, as well as empowering healthcare professionals to optimally manage their patients’ condition.

Roche Services (Europe) Ltd. was established in Budapest in 2006 as an affiliate of the Roche Group. From our office in the city center, we provide global support and consultancy to more than 120 Roche subsidiaries in finance, procurement, human resources and IT processes. Our 900 devoted, professionally qualified experts contribute to Roche’s success every day with excellent technical knowledge and business sense.

Our company gives donations to foundations and civil organisations for programmes that have health and scientific implications and are aimed at helping people in need. We take part in community and charity project with direct financial aid, education services and the direct physical contribution of our employees. In addition to financial help, we also organise a voluntary employee day each year to express our social responsibility.

If you are interested in health data from 30 European countries, including Hungary, if you want to know how the health systems of each country adapt to the health status of the population, if screening, diagnosing breast cancer and multiple sclerosis, treatment effectiveness is important to you, click link below, where you can perform comparisons and analyzes with the Future Proofing HealthCare Platform using thousands of data points and references.